• Lawyers in Sydney
• Lawyers in Melbourne
• Lawyers in Brisbane
• Lawyers in Perth
• Family lawyers
• Employment lawyers
• Criminal lawyers
• Wills and estates lawyers
• Find a lawyer

(a) under a request for a service, other than a request for a service described in paragraph (3) (a), no more than 6 tests are requested; and

(b) the tests are performed within 6 months of the request; and

(c) the account for the service is endorsed ‘Rule 3 Exemption’.

Note Rule 3 in the Health Insurance (Pathology Services Table) Regulations 2009 has been replaced by clause 1.2.2.

(2) For subclause (1), the pathology services are:

(a) estimation of prothrombin time (INR) for a patient undergoing anticoagulant therapy; and

(b) quantitative estimation of lithium for a patient undergoing lithium therapy; and

(c) a service described in item 65070 in relation to a patient undergoing chemotherapy for neoplastic disease or immunosuppressant therapy; and

(d) a service described in item 65070 in relation to clozaril, ticlopidine hydrochloride, methotrexate, gold, sulphasalazine or penicillamine therapy of a patient; and

(e) a service described in any of items 66500 to 66512, in relation to methotrexate or leflunomide therapy of a patient; and

(f) quantitative estimation of urea, creatinine and electrolytes in relation to:

(i) cis‑platinum or cyclosporin therapy of a patient; or

(ii) chronic renal failure of a patient being treated in a dialysis program conducted by a recognised hospital; and

(g) quantitative estimation of albumin and calcium in relation to therapy of a patient with vitamin D, its metabolites or analogues; and

(h) quantitative estimation of calcium, phosphate, magnesium, urea, creatinine and electrolytes for a cancer patient receiving bisphosphonate infusions.

1.2.4 Referral of designated tests by 1 1.2.4 Referral of designated tests by 1 pathology practitioner to another

1.2.4 Referral of designated tests by 1 pathology practitioner to another

(1) In this clause:

designated test means a pathology test relating to a patient episode that is a test of a kind mentioned in item 65150, 65175, 66650, 66695, 66711, 66722, 66785, 66800, 66812, 66819, 66825, 69384, 69494, 71089, 71153 or 77165.

(2) This clause applies if 1 or more designated tests are referred by a referring APP to a receiving APP in another approved pathology authority.
(3) If a referring APP has rendered 1 or more designated tests:

(a) the amount mentioned in item 65150, 65153, 65175, 65176, 65177, 65178, 66650, 66695, 66698, 66701, 66704, 66707, 66711, 66722, 66725, 66728, 66731, 66785, 66800, 66803, 66812, 66819, 66825, 69384, 69387, 69390, 69393, 69396, 69494, 69495, 71089, 71091, 71153, 71155, 71157, 77165, 71166 or 71167 (as the case may be) is payable for each designated test rendered by the referring APP; and

(b) subject to subclause (5), the amount mentioned in item 65158, 65181, 66652, 66697, 66715, 66724, 66790, 66805, 66817, 66821, 66827, 69401, 69498, 71092, 71156 or 71170 (as the case may be) is payable for each designated test rendered by the receiving APP.

(4) If a referring APP has not rendered a designated test:

(a) for the first designated test that is rendered by the receiving APP — the amount mentioned in item 65157 65180 66651 66696, 66714, 66723, 66789, 66804, 66816, 66820, 66826, 69400, 69497, 71090, 71154 or 71169 (as the case may be) is payable; and

(b) for each subsequent designated test (if any) that is rendered by the receiving APP — subject to subclause (6), the amount mentioned in item 65158, 65181, 66652, 66697, 66715, 66724, 66790, 66805, 66817, 66821, 66827, 69401, 69498, 71092, 71156 or 71170 (as the case may be) is payable for each test rendered.

(5) For paragraph (3) (b), the maximum number of designated tests for which the fee mentioned in the relevant item is payable is as follows:

(a) for item 66652, 66715, 66790, 66817, 66821 or 66827:

(b) for item 65158, 66805, 69498 or 71092:

(c) for item 71156 or 71170:

(d) for item 65181 or 66724:

where:

X is the number of designated tests rendered by a referring APP.

(6) For paragraph (4) (b), the maximum number of designated tests for which the fee mentioned in the relevant item is payable is as follows:

(a) for item 66652, 66715, 66790, 66817, 66821 or 66827 — 1;

(b) for item 65158, 66805, 69498 or 71092 — 2;

(c) for item 71156 or 71170 — 3;

(d) for item 65181 or 66724 — 4.

(7) Items in Group P10 (Patient episode initiation) do not apply to a receiving APP in subclause (2).

1.2.5 Items not to be split 1.2.5 Items not to be split

1.2.5 Items not to be split

Except as stated in clause 1.2.4 the amount mentioned in an item is payable only to 1 approved pathology practitioner for a single patient episode.

1.2.6 Certain pathology services to be t 1.2.6 Certain pathology services to be treated as 1 service

1.2.6 Certain pathology services to be treated as 1 service

(1) In this clause:

general practitioner has the meaning given by subclause 1.2.7 (1).

set of pathology services has the meaning given by subclause 1.2.7 (2).

(2) If a general practitioner, participating midwife or participating nurse practitioner requests a set of pathology services, the pathology services in the set are to be treated as individual pathology services in accordance with this clause.
(3) If the fee mentioned in 1 item that describes any of the services in the set of pathology services is higher than the fees mentioned in the other items that describe the services in the set:

(a) the pathology service described in the first‑mentioned item is to be treated as 1 pathology service; and

(b) either:

(i) the pathology service in the set that is described in the item that mentions the second‑highest fee is to be treated as 1 pathology service; or

(ii) if 2 or more items that describe any of those services mentions the second‑highest fee — the pathology service described in the item that mentions the second‑highest fee, and has the lowest item number, is to be treated as 1 pathology service; and

(c) the pathology services in the set, other than the services that are to be treated as 1 pathology service under paragraphs (a) and (b), are to be treated as 1 pathology service.

(4) If the fees mentioned in 2 or more items that describe any of the services in the set of pathology services are the same, and higher than the fees mentioned in the other items that describe the services in the set:

(a) the pathology service in the set that is described in the item that mentions the highest fee, and has the lowest item number, is to be treated as 1 pathology service; and

(b) the pathology service in the set that is described in the item that mentions the highest fee, and has the second‑lowest item number, is to be treated as 1 pathology service; and

(c) the pathology services in the set, other than the services that are to be treated as 1 pathology service under paragraphs (a) and (b), are to be treated as 1 pathology service.

(5) If pathology services are to be treated as 1 pathology service under paragraph (3) (c) or (4) (c), the fee for the 1 pathology service is the highest fee mentioned in any of the items that describe the pathology services that are to be treated as the 1 pathology service.

1.2.7 Meaning of general practitioner an 1.2.7 Meaning of general practitioner and set of pathology services

1.2.7 Meaning of general practitioner and set of pathology services

(1) In clause 1.2.6:

general practitioner means a medical practitioner who:

(a) is not a consultant physician in any specialty; and

(b) is not a specialist in any specialty.

(2) In clause 1.2.6 and subject to subclause (3):

set of pathology services means a group of pathology services:

(a) that consists of services that are described in at least 4 different items; and

(b) all of which are requested in a single patient episode; and

(c) each of which relates to a patient who is not an admitted patient of a hospital; and

(d) none of which is referred to in item 66900, 69484, 73053 or 73055.

(3) In clause 1.2.6, an item mentioned in this subclause is to be excluded from a set of pathology services:

(a) if a service is requested by an approved pathology practitioner of an approved pathology authority and rendered by another approved pathology practitioner of an approved pathology authority that is not related to the approved pathology authority of the first mentioned approved pathology practitioner — item 65079, 65082, 65157, 65158, 65166, 65180, 65181, 66606, 66609, 66610, 66639, 66642, 66651, 66652, 66663, 66666, 66696, 66697, 66714, 66715, 66723, 66724, 66780, 66783, 66789, 66790, 66792, 66804, 66805, 66816, 66817, 66820, 66821, 66826, 66827, 66832, 69325, 69328, 69331, 69379, 69383, 69400, 69401, 69419, 69451, 69489, 69492, 69497, 69498, 69500, 71076, 71090, 71092, 71096, 71148, 71154, 71156, 71169, 71170, 73309, 73312, 73315, 73318, 73321 or 73324; or

(b) an item in Group P10 (Patient episode initiation), Group P11 (Specimen referred), Group P12 (Management of bulk‑billed services) or Group P13 (Bulk billing incentive for episodes consisting of a P10 service).

(4) An approved pathology authority is related to another approved pathology authority for paragraph (3) (a) if:

(a) both approved pathology authorities are employed (including employed under contract) by the same person, whether or not the person is also an approved pathology authority; or

(b) either of the approved pathology authorities is employed (including employed under contract) by the other; or

(c) both approved pathology authorities are corporations and are connected entities within the meaning of the Corporations Act 2001; or

(d) the approved pathology authorities are partners (whether or not either or both of the approved pathology authorities are individuals and whether or not other persons are in partnership with either or both of the approved pathology authorities); or

(e) both approved pathology authorities are operated by the Commonwealth or an authority of the Commonwealth; or

(f) both approved pathology authorities are operated by the same State or internal Territory or an authority of the same State or internal Territory.

1.2.8 Satisfying requirements described 1.2.8 Satisfying requirements described in pathology service

1.2.8 Satisfying requirements described in pathology service

Unless the contrary intention appears, a requirement contained in the description of a pathology service in Part 2 is satisfied if:

(a) for a requirement for information — the information:

(i) is included in the request for the service; or

(ii) was supplied in writing on an earlier occasion to the approved pathology authority that rendered the service, and has been kept by the approved pathology authority; or

(b) for a requirement for laboratory test results — the results are:

(i) included in the request for the service; or

(ii) obtained from another laboratory test performed in the same patient episode; or

(iii) included in results from an earlier laboratory test that have been kept by the approved pathology authority.

Part 2 Services and fees

Division 2.1 Group P1 — Haematology

2.1.1 Services to which clause 1.2.2 doe 2.1.1 Services to which clause 1.2.2 does not apply

2.1.1 Services to which clause 1.2.2 does not apply

(1) Clause 1.2.2 of Division 1.2 does not apply to a pathology service described in item 65060, 65070, 65120, 65123, 65126, 65129, 65150, 65153 or 65156 if:

(a) the service is rendered in relation to 1 or more specimens taken on any of not more than 6 occasions in a period of 24 hours; and

(b) the service is rendered to an inpatient of a hospital; and

(c) the service is rendered in relation to each specimen as soon as possible after the specimen is taken; and

(d) the account for the service is endorsed ‘Rule 3 Exemption’.

Note Rule 3 in the Health Insurance (Pathology Services Table) Regulations 2009 has been replaced by clause 1.2.2.

(2) Clause 1.2.2 of Division 1.2 does not apply to a pathology service described in item 65109 or 65110 if:

(a) the service is rendered:

(i) for a service described in item 65109 — on 1 of not more than 5 occasions in a period of 24 hours; and

(ii) for a service described in item 65110 — on 1 of not more than 2 occasions in a period of 24 hours; and

(b) the service was requested on a separate occasion to any other occasions on which the service was requested in the period of 24 hours; and

(c) the account for the service is endorsed ‘Rule 3 Exemption’.

Note Rule 3 in the Health Insurance (Pathology Services Table) Regulations 2009 has been replaced by clause 1.2.2.

2.1.2 Item taken to refer only to the fi 2.1.2 Item taken to refer only to the first service of a particular kind

2.1.2 Item taken to refer only to the first service of a particular kind

(1) For an item in Group P1 (Haematology):

(a) if pathology services of a kind mentioned in item 65090 or 65093 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during the period; and

(b) if:

(i) tests (except tests mentioned in item 65099, 65102, 65105 or 65108) are carried out in relation to a patient episode; and

(ii) specimen material from the patient episode is stored; and

(iii) in response to a request made within 14 days of the patient episode, further tests (except tests mentioned in item 65099, 65102, 65105 or 65108) are carried out on the stored material;

the later tests and the earlier tests are taken to be part of 1 patient episode.

(2) Items 65102 and 65108 apply only if a minimum of 6 units are issued for a patient’s care in any

This is an opening excerpt, not the complete document.